CID 380631

3,4-dihydro-2h-[1,3]thiazino[3,2-a]benzimidazol-3-ol

Structural Information

Molecular Formula
C10H10N2OS
SMILES
C1C(CSC2=NC3=CC=CC=C3N21)O
InChI
InChI=1S/C10H10N2OS/c13-7-5-12-9-4-2-1-3-8(9)11-10(12)14-6-7/h1-4,7,13H,5-6H2
InChIKey
BLOJMWLHCBDQHM-UHFFFAOYSA-N
Compound name
3,4-dihydro-2H-[1,3]thiazino[3,2-a]benzimidazol-3-ol
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

10
References

5
Patents

206.05139 Da
Monoisotopic Mass

1.4
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 207.05867 139.4
[M+Na]+ 229.04061 150.4
[M-H]- 205.04411 141.6
[M+NH4]+ 224.08521 160.2
[M+K]+ 245.01455 145.9
[M+H-H2O]+ 189.04865 133.6
[M+HCOO]- 251.04959 154.2
[M+CH3COO]- 265.06524 152.5
[M+Na-2H]- 227.02606 145.0
[M]+ 206.05084 140.9
[M]- 206.05194 140.9
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe